Adding Bevacizumab to Paclitaxel in the First-Line Treatment of Metastatic Breast Cancer

被引:0
作者
Fox, Kevin R.
机构
关键词
Breast Cancer; Paclitaxel; Tamoxifen; Bevacizumab; Trastuzumab;
D O I
10.1007/s11912-009-0002-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:5 / 6
页数:2
相关论文
共 12 条
[1]  
Cobleigh M.(2001)Phase II dose escalation trial of Avastin (bevacizumab) in women with previously treated metastatic breast cancer Breast Cancer Res Treat 69 301-799
[2]  
Miller K.(2005)Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer J Clin Oncol 23 792-1802
[3]  
Langmuir V.(2003)A randomized trial of LET in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer N Engl J Med 349 1793-undefined
[4]  
Miller K.(2004)What is the prognosis of patients with operable breast cancer (BC) five years after diagnosis? J Clin Oncol 22 23s-undefined
[5]  
Chap L.(undefined)undefined undefined undefined undefined-undefined
[6]  
Homes F.(undefined)undefined undefined undefined undefined-undefined
[7]  
Goss P.(undefined)undefined undefined undefined undefined-undefined
[8]  
Ingle J.(undefined)undefined undefined undefined undefined-undefined
[9]  
Martino S.(undefined)undefined undefined undefined undefined-undefined
[10]  
Hortobagyi G.(undefined)undefined undefined undefined undefined-undefined